Renal Replacement Therapy
The Japanese Clinical Practice Guideline for acute kidney injury 2016
- Kent Doi,
- Osamu Nishida,
- Takashi Shigematsu,
- Tomohito Sadahiro,
- Noritomo Itami,
- Kunitoshi Iseki,
- Yukio Yuzawa,
- Hirokazu Okada,
- Daisuke Koya,
- Hideyasu Kiyomoto,
- Yugo Shibagaki,
- Kenichi Matsuda,
- Akihiko Kato,
- Terumasa Hayashi,
- Tomonari Ogawa,
- Tatsuo Tsukamoto,
- Eisei Noiri,
- Shigeo Negi,
- Koichi Kamei,
- Hirotsugu Kitayama,
- Naoki Kashihara,
- Toshiki Moriyama,
- Yoshio Terada and
- The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee
Renal Replacement Therapy20184:36
© Japanese Society for Dialysis Therapy 2018
- Received: 22 June 2018
- Accepted: 22 June 2018
- Published: 10 September 2018
Abstract
Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.
Keywords
- Acute kidney injury
- Atrial natriuretic peptide
- Biomarker
- Blood purification
- Long-term follow-up
- Nafamostat mesilate
.png)
No hay comentarios:
Publicar un comentario